Ryan Specialty (RYAN) to Release Quarterly Earnings on Wednesday

Ryan Specialty (NYSE:RYAN) is scheduled to release its earnings data after the market closes on Wednesday, October 30th. Analysts expect Ryan Specialty to post earnings of $0.41 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, August 1st. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. The business had revenue of $695.40 million for the quarter, compared to analysts’ expectations of $695.56 million. Ryan Specialty had a return on equity of 48.08% and a net margin of 10.21%. The business’s revenue for the quarter was up 18.9% on a year-over-year basis. During the same period last year, the firm posted $0.45 earnings per share. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ryan Specialty Stock Down 1.3 %

NYSE RYAN opened at $68.75 on Monday. The stock’s 50-day moving average price is $66.69 and its 200-day moving average price is $59.91. The company has a market capitalization of $17.91 billion, a P/E ratio of 129.72, a price-to-earnings-growth ratio of 1.54 and a beta of 0.62. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.81. Ryan Specialty has a 52 week low of $41.49 and a 52 week high of $73.10.

Ryan Specialty Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Tuesday, August 13th were given a $0.11 dividend. The ex-dividend date was Tuesday, August 13th. This represents a $0.44 annualized dividend and a dividend yield of 0.64%. Ryan Specialty’s payout ratio is 83.02%.

Insider Buying and Selling

In related news, President Timothy William Turner sold 2,000,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $62.45, for a total transaction of $124,900,000.00. Following the sale, the president now owns 8,095 shares of the company’s stock, valued at $505,532.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the company’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total transaction of $1,709,866.94. Following the transaction, the executive vice president now directly owns 24,845 shares of the company’s stock, valued at approximately $1,619,397.10. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Timothy William Turner sold 2,000,000 shares of the stock in a transaction on Friday, August 9th. The shares were sold at an average price of $62.45, for a total value of $124,900,000.00. Following the sale, the president now owns 8,095 shares of the company’s stock, valued at approximately $505,532.75. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,107,136 shares of company stock valued at $131,860,032 over the last three months. 11.10% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on RYAN shares. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $65.00 to $75.00 in a research note on Tuesday, September 24th. Barclays began coverage on Ryan Specialty in a research report on Wednesday, September 4th. They issued an “overweight” rating and a $76.00 price target for the company. Keefe, Bruyette & Woods reiterated an “outperform” rating and set a $62.00 price objective on shares of Ryan Specialty in a research report on Tuesday, July 2nd. Wells Fargo & Company increased their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. Finally, The Goldman Sachs Group lifted their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $70.33.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.